Cargando…

Identification of circulating microRNAs as potential biomarkers for hepatic necroinflammation in patients with autoimmune hepatitis

OBJECTIVE: MicroRNAs (miRNAs) are implicated in the pathogenesis of autoimmune diseases and could be biomarkers of disease activity. This study aimed to identify highly expressed circulating miRNAs in patients with autoimmune hepatitis (AIH) and to evaluate their association with clinical characteri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saeki, Chisato, Matsuzaki, Juntaro, Kuroda, Masahiko, Fujita, Koji, Ichikawa, Makiko, Takizawa, Satoko, Takano, Keiko, Oikawa, Tsunekazu, Nakanuma, Yasuni, Saruta, Masayuki, Ochiya, Takahiro, Tsubota, Akihito
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2022
Materias:	Hepatology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8981297/ https://www.ncbi.nlm.nih.gov/pubmed/35379653 http://dx.doi.org/10.1136/bmjgast-2022-000879

Ejemplares similares

Relationship between osteoporosis, sarcopenia, vertebral fracture, and osteosarcopenia in patients with primary biliary cholangitis
por: Saeki, Chisato, et al.
Publicado: (2020)

Low Serum Branched-chain Amino Acid and Insulin-Like Growth Factor-1 Levels Are Associated with Sarcopenia and Slow Gait Speed in Patients with Liver Cirrhosis
por: Saeki, Chisato, et al.
Publicado: (2020)

Effects of denosumab treatment in chronic liver disease patients with osteoporosis
por: Saeki, Chisato, et al.
Publicado: (2020)

Low Serum 25-Hydroxyvitamin D Levels Are Related to Frailty and Sarcopenia in Patients with Chronic Liver Disease
por: Saeki, Chisato, et al.
Publicado: (2020)

Clinical characteristics of sarcopenia in patients with alcoholic liver cirrhosis
por: Saeki, Chisato, et al.
Publicado: (2021)

Serum Insulin-Like Growth Factor 1 Levels, Facture Risk Assessment Tool Scores and Bone Disorders in Patients with Primary Biliary Cholangitis
por: Saeki, Chisato, et al.
Publicado: (2022)

Relationship between Osteosarcopenia and Frailty in Patients with Chronic Liver Disease
por: Saeki, Chisato, et al.
Publicado: (2020)

Plasma pentosidine levels are associated with prevalent fractures in patients with chronic liver disease
por: Saeki, Chisato, et al.
Publicado: (2021)

Clinical Usefulness of FRAX Score for Predicting Sarcopenia in Patients with Chronic Liver Disease
por: Saeki, Chisato, et al.
Publicado: (2021)

Prognostic significance of sarcopenia and severe vitamin D deficiency in patients with cirrhosis
por: Saeki, Chisato, et al.
Publicado: (2023)

Insulin-like growth factor 1 predicts decompensation and long-term prognosis in patients with compensated cirrhosis
por: Saeki, Chisato, et al.
Publicado: (2023)

Osteosarcopenia predicts poor survival in patients with cirrhosis: a retrospective study
por: Saeki, Chisato, et al.
Publicado: (2023)

Circulating microRNAs: Challenges with their use as liquid biopsy biomarkers
por: Takizawa, Satoko, et al.
Publicado: (2022)

Comparative assessment of sarcopenia using the JSH, AWGS, and EWGSOP2 criteria and the relationship between sarcopenia, osteoporosis, and osteosarcopenia in patients with liver cirrhosis
por: Saeki, Chisato, et al.
Publicado: (2019)

The Geriatric Nutritional Risk Index predicts sarcopenia in patients with cirrhosis
por: Saeki, Chisato, et al.
Publicado: (2023)

Risk factors for acute hepatitis B and its progression to chronic hepatitis in Shanghai, China
por: Zhang, H W, et al.
Publicado: (2008)

Response to letter regarding: development of plasma ghrelin level as a novel marker for gastric mucosal atrophy after Helicobacter pylori eradication
por: Mori, Hideki, et al.
Publicado: (2022)

Primary hepatic large B-cell lymphoma following direct-acting antiviral treatment for hepatitis C
por: Zaimi, Yosra, et al.
Publicado: (2021)

An educational tool for the prophylaxis of hepatic encephalopathy
por: Garrido, Maria, et al.
Publicado: (2017)

Pretreatment prediction of the outcome of response-guided peginterferon-α and ribavirin therapy for chronic hepatitis C
por: Masaki, Naohiko, et al.
Publicado: (2014)

Hepatitis C elimination in the Netherlands (CELINE): study protocol for nationwide retrieval of lost to follow-up patients with chronic hepatitis C
por: Isfordink, Cas J, et al.
Publicado: (2020)

Centrilobular zonal necrosis is a unique subtype of autoimmune hepatitis: A cohort study
por: Ueda, Kaoru, et al.
Publicado: (2022)

Loss of hepatic Mboat7 leads to liver fibrosis
por: Thangapandi, Veera Raghavan, et al.
Publicado: (2021)

Managing hepatic complications of pregnancy: practical strategies for clinicians
por: Morrison, Maura Alice, et al.
Publicado: (2022)

Low geriatric nutritional risk index predicts poor prognosis in patients with cirrhosis: a retrospective study
por: Kamioka, Hiroshi, et al.
Publicado: (2023)

In vivo evidence for ribavirin-induced mutagenesis of the hepatitis E virus genome
por: Todt, Daniel, et al.
Publicado: (2016)

Low yield of head CT in cirrhotic patients presenting with hepatic encephalopathy
por: Hanna, Angy, et al.
Publicado: (2021)

Baseline quantitative hepatitis B core antibody titre alone strongly predicts HBeAg seroconversion across chronic hepatitis B patients treated with peginterferon or nucleos(t)ide analogues
por: Fan, Rong, et al.
Publicado: (2016)

Hepatic decompensation in the absence of obvious precipitants: the potential role of cytomegalovirus infection/reactivation
por: Rosi, Silvia, et al.
Publicado: (2015)

miRNA-132 induces hepatic steatosis and hyperlipidaemia by synergistic multitarget suppression
por: Hanin, Geula, et al.
Publicado: (2018)

Effect of season and sunlight on viral kinetics during hepatitis C virus therapy
por: Hernández-Alvarez, Noemi, et al.
Publicado: (2017)

Clinical usefulness of ursodeoxycholic acid for Japanese patients with autoimmune hepatitis
por: Torisu, Yuichi, et al.
Publicado: (2017)

Safety and on-treatment efficacy of telaprevir: the early access programme for patients with advanced hepatitis C
por: Colombo, M, et al.
Publicado: (2014)

Comparable efficacy with entecavir monotherapy and tenofovir–entecavir combination in chronic hepatitis B patients
por: Baqai, Sumbella, et al.
Publicado: (2015)

MerTK expressing hepatic macrophages promote the resolution of inflammation in acute liver failure
por: Triantafyllou, Evangelos, et al.
Publicado: (2018)

Neuropsychiatric performance and treatment of hepatitis C with direct-acting antivirals: a prospective study
por: Volpato, Sofia, et al.
Publicado: (2017)

Autoantibodies in chronic hepatitis C virus infection: impact on clinical outcomes and extrahepatic manifestations
por: Gilman, Andrew J, et al.
Publicado: (2018)

Efficient acute and chronic infection of stem cell-derived hepatocytes by hepatitis C virus
por: Carpentier, Arnaud, et al.
Publicado: (2020)

Unexpected clinical outcomes following the implementation of a standardised order set for hepatic encephalopathy
por: KC, Mandip, et al.
Publicado: (2021)

Association of exercise participation levels with cardiometabolic health and quality of life in individuals with hepatitis C
por: Hallsworth, Kate, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_injk10mf17i1jlj7aerv21gk1j